RheinCell Therapeutics GmbH, a developer and manufacturer of human induced pluripotent stem cells (iPSCs) as starting materials for cell therapies, announced it has received Good Manufacturing Practice (GMP) certification and Manufacturing Authorization ...
Weiterlesen …

In recent years, issues such as climate change, finite resources and a growing world population have increasingly become the focus of society and politics. To meet the challenges of our time, innovative ...
Weiterlesen …

For the 11th time, BIO.NRW is publishing the brochure "Spot on Biotechnology Business". As usual, BIO.NRW presents an analysis of the local industry and provides facts and figures on biotechnology in NRW ...
Weiterlesen …

Definitions, backgrounds, specific funding tools and relevance for NR is discussed. The bioeconomy now has its own tab on the BIO.NRW homepage ...
Weiterlesen …

The Federal Ministry of Education and Research (BMBF) and the Federal Ministry of Food and Agriculture (BMEL) have appointed the members of the new Bioeconomy Council. They met in digital form on ...
Weiterlesen …

The Compassionate Use Program (CUP) may provide access to pritelivir for use in immunocompromised patients that have acyclovir-resistant mucocutaneous herpes simplex virus infections and foscarnet resistance or intolerance CUPs offer a method ...
Weiterlesen …

The Webinare is part of a series by EuropaBio on  "How does the EU support small – and medium sized biotech?" Wednesday, December 9, 2020 2:00 pm - 3:30 pm Europe Time ...
Weiterlesen …

InfanDx AG, a diagnostics company specialized in the development of biomarker-based tests, today announced the completion of recruitment for its two-year follow-up study AAMBI2 (Asphyxia Associated Metabolite Biomarker Investigation 2). The study ...
Weiterlesen …